Omeros Corporation (OMER)
USD 7.16
(6.87%)
USD 7.16
(6.87%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 338.28 Million USD | 5.72% |
| 2022 | 342.02 Million USD | -1.67% |
| 2021 | 347.83 Million USD | 968.56% |
| 2020 | 32.55 Million USD | -9.13% |
| 2019 | 35.82 Million USD | -76.35% |
| 2018 | 151.44 Million USD | 79.0% |
| 2017 | 84.6 Million USD | 6.14% |
| 2016 | 79.71 Million USD | 59.93% |
| 2015 | 49.84 Million USD | 52.38% |
| 2014 | 32.7 Million USD | 59.57% |
| 2013 | 20.49 Million USD | 1.96% |
| 2012 | 20.1 Million USD | 3.38% |
| 2011 | 19.44 Million USD | 99.34% |
| 2010 | 9.75 Million USD | -23.54% |
| 2009 | 12.75 Million USD | -23.49% |
| 2008 | 16.67 Million USD | 1550.89% |
| 2007 | 1.01 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 472.14 Million USD | 30.58% |
| 2024 Q2 | 444.35 Million USD | -5.89% |
| 2023 Q3 | 340.87 Million USD | -0.14% |
| 2023 Q4 | 361.58 Million USD | 6.08% |
| 2023 Q1 | 341.47 Million USD | -0.16% |
| 2023 FY | 361.58 Million USD | 5.72% |
| 2023 Q2 | 341.35 Million USD | -0.04% |
| 2022 Q2 | 343.02 Million USD | 0.26% |
| 2022 Q3 | 342.76 Million USD | -0.08% |
| 2022 Q4 | 342.02 Million USD | -0.22% |
| 2022 FY | 342.02 Million USD | -1.67% |
| 2022 Q1 | 342.12 Million USD | -1.64% |
| 2021 Q2 | 348.86 Million USD | 1.48% |
| 2021 FY | 347.83 Million USD | 968.56% |
| 2021 Q4 | 347.83 Million USD | -0.16% |
| 2021 Q3 | 348.4 Million USD | -0.13% |
| 2021 Q1 | 343.76 Million USD | 956.06% |
| 2020 Q2 | 197.61 Million USD | 0.96% |
| 2020 Q3 | 266.27 Million USD | 34.75% |
| 2020 FY | 32.55 Million USD | -9.13% |
| 2020 Q4 | 32.55 Million USD | -87.78% |
| 2020 Q1 | 195.73 Million USD | 446.42% |
| 2019 Q1 | 180.32 Million USD | 19.06% |
| 2019 FY | 35.82 Million USD | -76.35% |
| 2019 Q4 | 35.82 Million USD | 12.97% |
| 2019 Q3 | 31.7 Million USD | -82.58% |
| 2019 Q2 | 181.99 Million USD | 0.93% |
| 2018 Q2 | 130.35 Million USD | 52.38% |
| 2018 Q1 | 85.55 Million USD | 1.11% |
| 2018 FY | 151.44 Million USD | 79.0% |
| 2018 Q4 | 151.44 Million USD | 14.51% |
| 2018 Q3 | 132.25 Million USD | 1.46% |
| 2017 Q3 | 83.14 Million USD | 1.69% |
| 2017 Q2 | 81.76 Million USD | 1.28% |
| 2017 Q1 | 80.73 Million USD | 1.28% |
| 2017 FY | 84.6 Million USD | 6.14% |
| 2017 Q4 | 84.6 Million USD | 1.76% |
| 2016 Q3 | 70.47 Million USD | 0.65% |
| 2016 Q1 | 50.04 Million USD | 0.4% |
| 2016 FY | 79.71 Million USD | 59.93% |
| 2016 Q4 | 79.71 Million USD | 13.1% |
| 2016 Q2 | 70.02 Million USD | 39.93% |
| 2015 Q1 | 32.92 Million USD | 0.66% |
| 2015 FY | 49.84 Million USD | 52.38% |
| 2015 Q4 | 49.84 Million USD | 74.57% |
| 2015 Q3 | 28.55 Million USD | -7.21% |
| 2015 Q2 | 30.77 Million USD | -6.54% |
| 2014 FY | 32.7 Million USD | 59.57% |
| 2014 Q4 | 32.7 Million USD | 0.51% |
| 2014 Q3 | 32.54 Million USD | 0.53% |
| 2014 Q2 | 32.37 Million USD | 0.49% |
| 2014 Q1 | 32.21 Million USD | 57.15% |
| 2013 FY | 20.49 Million USD | 1.96% |
| 2013 Q4 | 20.49 Million USD | 0.51% |
| 2013 Q2 | 20.29 Million USD | 0.48% |
| 2013 Q1 | 20.19 Million USD | 0.47% |
| 2013 Q3 | 20.39 Million USD | 0.5% |
| 2012 Q3 | 15.05 Million USD | -9.08% |
| 2012 FY | 20.1 Million USD | 3.38% |
| 2012 Q2 | 16.55 Million USD | -8.12% |
| 2012 Q4 | 20.1 Million USD | 33.56% |
| 2012 Q1 | 18.01 Million USD | -7.34% |
| 2011 Q4 | 19.44 Million USD | -4.52% |
| 2011 FY | 19.44 Million USD | 99.34% |
| 2011 Q3 | 20.36 Million USD | 0.27% |
| 2011 Q2 | 20.31 Million USD | 0.26% |
| 2011 Q1 | 20.26 Million USD | 107.69% |
| 2010 Q4 | 9.75 Million USD | 9.12% |
| 2010 Q2 | 10.14 Million USD | -11.65% |
| 2010 FY | 9.75 Million USD | -23.54% |
| 2010 Q1 | 11.48 Million USD | -10.02% |
| 2010 Q3 | 8.94 Million USD | -11.86% |
| 2009 FY | 12.75 Million USD | -23.49% |
| 2009 Q4 | 12.75 Million USD | -8.83% |
| 2009 Q3 | 13.99 Million USD | -7.89% |
| 2009 Q2 | 15.19 Million USD | 0.0% |
| 2008 Q4 | 16.67 Million USD | 0.0% |
| 2008 FY | 16.67 Million USD | 1550.89% |
| 2007 FY | 1.01 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dyadic International, Inc. | 136.92 Thousand USD | -246948.47% |
| Agenus Inc. | 350.24 Million USD | 3.416% |
| AlloVir, Inc. | 27.42 Million USD | -1133.297% |
| Ardelyx, Inc. | 55.98 Million USD | -504.267% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1492.735% |
| Chimerix, Inc. | 2.14 Million USD | -15678.032% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1519.791% |
| CRISPR Therapeutics AG | 238.63 Million USD | -41.758% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -5057.509% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -226.728% |
| Fortress Biotech, Inc. | 88.59 Million USD | -281.841% |
| Fortress Biotech, Inc. | 88.59 Million USD | -281.841% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -6101.302% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -613116.713% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -214001.899% |
| IO Biotech, Inc. | 2.49 Million USD | -13463.793% |
| Structure Therapeutics Inc. | 5.45 Million USD | -6103.575% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -5387.121% |
| MiMedx Group, Inc. | 48.09 Million USD | -603.302% |
| Senti Biosciences, Inc. | 37.66 Million USD | -798.107% |
| Opthea Limited | 200.62 Million USD | -68.61% |
| Pharming Group N.V. | 171.54 Million USD | -97.197% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 25.51 Million USD | -1225.968% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -458.413% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1022.477% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -787.783% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -188.653% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -444.955% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -334831.683% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -37237.859% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1318.273% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -20589.969% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -395.795% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -643.311% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -953.244% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -47.598% |
| Clearside Biomedical, Inc. | 43 Million USD | -686.682% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -2665.993% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -151.503% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -34846.384% |
| Vaxxinity, Inc. | 15.16 Million USD | -2130.228% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1223.685% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -4716.073% |
| Aptorum Group Limited | 3.36 Million USD | -9960.71% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -5418.45% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -11678.586% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -224.702% |
| ContextLogic Inc. | 6 Million USD | -5538.017% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -233.663% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -376.613% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -421024.639% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1485.866% |
| Royalty Pharma plc | 6.13 Billion USD | 94.486% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -60.978% |
| TG Therapeutics, Inc. | 110.79 Million USD | -205.322% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -851.423% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1278.376% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -74978.29% |
| Seer, Inc. | 28.25 Million USD | -1097.073% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -116692.396% |
| NextCure, Inc. | 6.6 Million USD | -5021.59% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -106277.673% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -15856.651% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -143.315% |
| AnaptysBio, Inc. | 17.81 Million USD | -1798.961% |
| ChromaDex Corporation | 3.27 Million USD | -10222.887% |
| Precigen, Inc. | 7.09 Million USD | -4666.535% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1085.246% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1130.784% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -20364.67% |
| Acelyrin, Inc. | 1.19 Million USD | -28231.742% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -5349.114% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -4317.702% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2242.017% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -144174.132% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2506.975% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -59772.743% |
| AbCellera Biologics Inc. | 77.38 Million USD | -337.169% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 87.39% |
| Bicycle Therapeutics plc | 44.95 Million USD | -652.471% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -41745.641% |
| Incyte Corporation | 38.28 Million USD | -783.54% |
| Alkermes plc | 290.73 Million USD | -16.356% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -19952.223% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -3321.898% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -3333.628% |
| Geron Corporation | 85.89 Million USD | -293.813% |
| Summit Therapeutics Inc. | 106.09 Million USD | -218.835% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -4849.247% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1909.988% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -54285.751% |
| Innoviva, Inc. | 449.07 Million USD | 24.672% |
| Jaguar Health, Inc. | 35.86 Million USD | -843.338% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -71117.053% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -206.531% |
| Vaxcyte, Inc. | 29.22 Million USD | -1057.545% |
| ADMA Biologics, Inc. | 141.41 Million USD | -139.206% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -193.721% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -157975.234% |
| Novavax, Inc. | 280.63 Million USD | -20.541% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1639.681% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -112392.601% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -19419.965% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -9410.29% |
| Precision BioSciences, Inc. | 31.26 Million USD | -981.876% |
| GT Biopharma, Inc. | 58 Thousand USD | -583143.103% |
| ImmuCell Corporation | 11.96 Million USD | -2726.238% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | -184.454% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1250.855% |
| Aptose Biosciences Inc. | 1 Million USD | -33399.603% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -3907952.218% |
| Soligenix, Inc. | 3.49 Million USD | -9580.214% |
| Century Therapeutics, Inc. | 48.17 Million USD | -602.25% |
| Kura Oncology, Inc. | 17.2 Million USD | -1866.75% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -265.974% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -15634.0% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2320.789% |
| Autolus Therapeutics plc | 52.96 Million USD | -538.664% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -6085.427% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -708.453% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -47.443% |
| GRI Bio, Inc. | 14 Thousand USD | -2416192.857% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2622.803% |
| IGM Biosciences, Inc. | 40.5 Million USD | -735.138% |
| INmune Bio, Inc. | 10.43 Million USD | -3141.171% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -88.323% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5626.725% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -414054.016% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -40812.312% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -553.367% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -480.431% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -484.533% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 29.648% |
| Verastem, Inc. | 41.55 Million USD | -714.017% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -6164.463% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2874.683% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -3347.274% |
| Histogen Inc. | 4.62 Million USD | -7218.931% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -9911.276% |
| Organovo Holdings, Inc. | 1.39 Million USD | -24166.93% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -635.366% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -6412.919% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1584354.333% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -299.916% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -161741.451% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1019.543% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -208307.622% |
| Apollomics, Inc. | 4.66 Million USD | -7157.691% |
| Amarin Corporation plc | 8.73 Million USD | -3771.821% |
| Turnstone Biologics Corp. | 3.21 Million USD | -10425.233% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -299.51% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -136855.87% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -246.575% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -78.095% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2173.394% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1004.988% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -204.955% |
| NLS Pharmaceutics AG | 1.63 Million USD | -20605.85% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -222.864% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -12042.175% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -692105.852% |
| Avid Bioservices, Inc. | 207.83 Million USD | -62.765% |
| Insmed Incorporated | 1.2 Billion USD | 71.903% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -4940.694% |
| OmniAb, Inc. | 25.56 Million USD | -1223.426% |
| Alector, Inc. | 38.91 Million USD | -769.215% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -58.123% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2132.731% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 29.294% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1629.718% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -435.534% |
| Immunic, Inc. | 1.33 Million USD | -25258.396% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -966.056% |
| Veracyte, Inc. | 12.63 Million USD | -2578.393% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 47.542% |
| FibroGen, Inc. | 170.45 Million USD | -98.458% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3625.151% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -165796.396% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 94.164% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -914172.973% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -7883.975% |
| Galecto, Inc. | 249 Thousand USD | -135755.823% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -20204.982% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 79.84% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -4523.22% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -6167.945% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -12042.175% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1158.439% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -650.518% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -23739.394% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -647.814% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -683.62% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -601.406% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 60.142% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -32825.994% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -2987.914% |
| NexImmune, Inc. | 68.8 Thousand USD | -491523.189% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2383167.578% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 87.485% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -86195.733% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -4798.364% |
| Ainos, Inc. | 5.96 Million USD | -5572.471% |
| Pluri Inc. | 29.61 Million USD | -1042.378% |
| Prothena Corporation plc | 11.83 Million USD | -2758.31% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1240.523% |
| Celularity Inc. | 65.41 Million USD | -417.115% |
| Rallybio Corporation | 392 Thousand USD | -86196.173% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2202.014% |
| MeiraGTx Holdings plc | 89.26 Million USD | -278.967% |
| Humacyte, Inc. | 58.1 Million USD | -482.179% |
| Immunocore Holdings plc | 84.03 Million USD | -302.562% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -18155.855% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -6836.252% |
| Blueprint Medicines Corporation | 774.12 Million USD | 56.301% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -6641.351% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -447.221% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -224.97% |
| Pulmatrix, Inc. | 8.75 Million USD | -3763.419% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -4790.574% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2342.462% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -193.275% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -972.274% |
| Cytokinetics, Incorporated | 755.77 Million USD | 55.24% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2427.503% |
| Nutriband Inc. | 241.28 Thousand USD | -140099.764% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -6087.69% |
| Vor Biopharma Inc. | 35.66 Million USD | -848.629% |
| Roivant Sciences Ltd. | 499.74 Million USD | 32.31% |
| Evogene Ltd. | 1.13 Million USD | -29625.923% |
| ProKidney Corp. | 4.41 Million USD | -7565.556% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -27492.251% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 80.557% |
| CorMedix Inc. | 667.63 Thousand USD | -50568.782% |
| BioLineRx Ltd. | 11.59 Million USD | -2818.48% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -769.17% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -371.098% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1953.174% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -13701.777% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -50015.704% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -639.04% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -520332.308% |
| MediciNova, Inc. | 215.92 Thousand USD | -156565.246% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -13458.357% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -26725.812% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -81.508% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3185.557% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 18.492% |
| Mereo BioPharma Group plc | 5.95 Million USD | -5583.485% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -9322.869% |
| Absci Corporation | 15.95 Million USD | -2019.954% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3592.621% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2205.78% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1133.927% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -2659.675% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2604.95% |
| Allakos Inc. | 41.46 Million USD | -715.823% |
| Imunon, Inc. | 1.62 Million USD | -20720.957% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3026.153% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -223927.152% |
| BioAtla, Inc. | 2.46 Million USD | -13651.26% |
| NLS Pharmaceutics AG | 1.63 Million USD | -20605.85% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -299263.717% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -255.632% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -5999.549% |
| XOMA Corporation | 124.45 Million USD | -171.821% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1686.727% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -683.656% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2141.014% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -2937.179% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1198.933% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1507.188% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -96828.653% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -103510.491% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -20631.496% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 77.437% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -206210.416% |
| UroGen Pharma Ltd. | 100.21 Million USD | -237.559% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -85.107% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -97572.532% |
| Orgenesis Inc. | 22.62 Million USD | -1395.429% |
| Entera Bio Ltd. | 390 Thousand USD | -86638.718% |
| GH Research PLC | 343 Thousand USD | -98524.198% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -110811.803% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -34666.804% |
| Xencor, Inc. | 83.43 Million USD | -305.447% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -195808.451% |
| Replimune Group, Inc. | 75.86 Million USD | -345.875% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -27532.235% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -3497.203% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -206210.416% |
| Portage Biotech Inc. | 47 Thousand USD | -719646.809% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -26725.812% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -13895.904% |
| OncoCyte Corporation | 2.86 Million USD | -11690.903% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -25937.318% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -224590.809% |
| Purple Biotech Ltd. | 351 Thousand USD | -96276.353% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -10608.484% |
| scPharmaceuticals Inc. | 40.26 Million USD | -740.053% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -560.795% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -238126.056% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -6366.851% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1165.169% |
| Curis, Inc. | 2.79 Million USD | -12007.409% |
| Daré Bioscience, Inc. | 5.31 Million USD | -6260.883% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -15733.797% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1921.882% |
| BeiGene, Ltd. | 930.18 Million USD | 63.633% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2076.49% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -284.655% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -29547.765% |
| Erasca, Inc. | 55.85 Million USD | -505.598% |
| bluebird bio, Inc. | 330.32 Million USD | -2.408% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 70.166% |
| DBV Technologies S.A. | 14.38 Million USD | -2252.277% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -13420.424% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -7184.259% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 16.429% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -634.771% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -7239.575% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -13207.671% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1694.309% |
| MacroGenics, Inc. | 33.97 Million USD | -895.793% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1516.713% |
| Prime Medicine, Inc. | 13.63 Million USD | -2381.339% |
| Aditxt, Inc. | 18.21 Million USD | -1756.852% |
| Adagene Inc. | 22.3 Million USD | -1416.488% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2110.553% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 44.632% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1566.984% |
| SciSparc Ltd. | 76 Thousand USD | -445006.579% |
| Vericel Corporation | 88.14 Million USD | -283.787% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -312.453% |
| Generation Bio Co. | 97.89 Million USD | -245.558% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -102720.973% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1237.185% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -64.281% |
| Invivyd, Inc. | 2.16 Million USD | -15524.988% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -532.703% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -9599982.867% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -6002.85% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -536853.968% |
| 2seventy bio, Inc. | 256.67 Million USD | -31.795% |
| Clene Inc. | 32.16 Million USD | -951.836% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -5927.65% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -15311.435% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -567.59% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -70192.886% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -75.101% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1022.887% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1867.093% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -171.624% |
| Evaxion Biotech A/S | 10.86 Million USD | -3012.153% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -305.666% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -351.601% |
| Trevena, Inc. | 35.23 Million USD | -860.125% |
| Surrozen, Inc. | 3.37 Million USD | -9911.276% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -5107.528% |
| Cingulate Inc. | 3.13 Million USD | -10690.122% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -824975.61% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1153.357% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -67434.233% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -55999.668% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -491.349% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -72648.602% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1096.523% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1573.085% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -21654.405% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -26747.698% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1980.303% |
| ImmunityBio, Inc. | 883.67 Million USD | 61.719% |
| Korro Bio, Inc. | 33.2 Million USD | -918.704% |
| Kineta, Inc. | 1.31 Million USD | -25585.725% |
| BioVie Inc. | 6.11 Million USD | -5435.203% |
| Codexis, Inc. | 22.36 Million USD | -1412.614% |
| Celularity Inc. | 65.41 Million USD | -417.115% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -553.961% |
| Celcuity Inc. | 37.44 Million USD | -803.377% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -150716.317% |
| Cibus, Inc. | 24.62 Million USD | -1273.953% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -88224.021% |
| IN8bio, Inc. | 4.89 Million USD | -6813.57% |
| Kodiak Sciences Inc. | 181.63 Million USD | -86.245% |
| Annexon, Inc. | 31.35 Million USD | -978.874% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -350.825% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -14344.108% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -8567.205% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 76.727% |
| Eyenovia, Inc. | 16.1 Million USD | -2000.112% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -203.418% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -34243.249% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -2852.614% |
| Arcellx, Inc. | 97.62 Million USD | -246.511% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -15641.322% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1175.906% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -10805.255% |
| Moolec Science SA | 2.64 Million USD | -12688.055% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1087.493% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -5258.482% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -13983.306% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -293409.119% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -899.944% |
| Humacyte, Inc. | 58.1 Million USD | -482.179% |
| 89bio, Inc. | 27.1 Million USD | -1147.901% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2446.146% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -13329.178% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -25182.586% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -218.94% |
| Notable Labs, Ltd. | 2.04 Million USD | -16409.566% |
| Liquidia Corporation | 3.5 Million USD | -9556.894% |
| Mustang Bio, Inc. | 2.49 Million USD | -13442.074% |
| Immunovant, Inc. | 138 Thousand USD | -245031.159% |
| Quantum-Si incorporated | 15.3 Million USD | -2110.553% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -3778.924% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -84470.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -529.852% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -414054.016% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3002.641% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -160611.961% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -166540.887% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1537.292% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -83840.695% |
| PepGen Inc. | 20.1 Million USD | -1582.655% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -58833.972% |
| United Therapeutics Corporation | 700 Million USD | 51.674% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1187.954% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -7479.747% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -38080.7% |
| XOMA Corporation | 124.45 Million USD | -171.821% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -123360.219% |
| Bionomics Limited | 239.61 Million USD | -41.175% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -16531.326% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2448.064% |
| uniQure N.V. | 138.4 Million USD | -144.407% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -296.007% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -32679.167% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -34243.249% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3625.151% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -19263.537% |
| Altimmune, Inc. | 671 Thousand USD | -50314.456% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 23.992% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2448.064% |
| Compugen Ltd. | 1.35 Million USD | -24939.304% |
| Peak Bio, Inc. | 10.72 Million USD | -3055.075% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -691.005% |
| Benitec Biopharma Inc. | 284 Thousand USD | -119013.028% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -300.072% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1598.113% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -2771.899% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -269.876% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1598.113% |
| Instil Bio, Inc. | 86.05 Million USD | -293.103% |
| argenx SE | 20 Million USD | -1591.405% |
| Immunome, Inc. | 1.65 Million USD | -20401.879% |
| Verona Pharma plc | 51.32 Million USD | -559.045% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -3359.613% |
| Shattuck Labs, Inc. | 4.2 Million USD | -7950.476% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -93347.79% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -7990.911% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -57725.812% |
| Moolec Science SA | 2.64 Million USD | -12688.055% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1019.793% |
| Design Therapeutics, Inc. | 3.05 Million USD | -10991.18% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -129014.885% |
| NeurAxis, Inc. | 224.26 Thousand USD | -150743.218% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2277.572% |
| Lumos Pharma, Inc. | 6.58 Million USD | -5037.145% |
| Achilles Therapeutics plc | 4.61 Million USD | -7230.033% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -3359.613% |
| 180 Life Sciences Corp. | 1.32 Million USD | -25526.009% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1880.554% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -21654.405% |
| Nutriband Inc. | 241.28 Thousand USD | -140099.764% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3212.259% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -40854.116% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 9.483% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1023.894% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -9048.006% |
| Palisade Bio, Inc. | 369 Thousand USD | -91575.068% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -81413.494% |
| Beam Therapeutics Inc. | 173.17 Million USD | -95.343% |
| Neurogene Inc. | 16.25 Million USD | -1981.089% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -9.781% |
| AEON Biopharma, Inc. | 278 Thousand USD | -121583.813% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -100879.403% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -316372.856% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -345.916% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -453.588% |
| Athira Pharma, Inc. | 1.58 Million USD | -21242.65% |
| Vaccinex, Inc. | 247 Thousand USD | -136855.87% |
| HCW Biologics Inc. | 6.45 Million USD | -5143.222% |
| XOMA Corporation | 124.45 Million USD | -171.821% |
| Nektar Therapeutics | 230.4 Million USD | -46.823% |
| Arvinas, Inc. | 3.4 Million USD | -9849.441% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -20631.496% |
| Merus N.V. | 12.16 Million USD | -2681.459% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -163.401% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2348.827% |
| Rezolute, Inc. | 2.22 Million USD | -15083.169% |
| Clene Inc. | 32.16 Million USD | -951.836% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -193144.903% |
| BeyondSpring Inc. | 3.99 Million USD | -8367.61% |
| Synlogic, Inc. | 17.27 Million USD | -1858.211% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -25921.615% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -966417.143% |
| Peak Bio, Inc. | 10.72 Million USD | -3055.075% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -551.505% |
| Krystal Biotech, Inc. | 8.09 Million USD | -4079.405% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -91.102% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -4693.553% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -247554.363% |
| MannKind Corporation | 382.37 Million USD | 11.533% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3050.317% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -82609.291% |
| Gossamer Bio, Inc. | 212.46 Million USD | -59.218% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -194314.368% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3592.621% |
| Legend Biotech Corporation | 328.67 Million USD | -2.924% |
| Mural Oncology plc | 15 Million USD | -2153.854% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -613.282% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -16000.952% |
| Champions Oncology, Inc. | 7.43 Million USD | -4452.907% |
| REGENXBIO Inc. | 89.29 Million USD | -278.857% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -39479.056% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -61073.962% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -6148.264% |
| Vaxart, Inc. | 26.51 Million USD | -1175.858% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2060.524% |
| Cellectis S.A. | 92.85 Million USD | -264.319% |
| Longeveron Inc. | 2.04 Million USD | -16474.277% |
| Repare Therapeutics Inc. | 3.41 Million USD | -9820.264% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 75.782% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -626.05% |
| Revolution Medicines, Inc. | 87.94 Million USD | -284.655% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -195438.15% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -8457.577% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -106613.249% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -193203.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 58.154% |
| Denali Therapeutics Inc. | 52.24 Million USD | -547.539% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2248.283% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -24520.16% |
| Cingulate Inc. | 3.13 Million USD | -10690.122% |
| Passage Bio, Inc. | 26.29 Million USD | -1186.533% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -4975.484% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -82812.01% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -37739.038% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1545.256% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -26747.698% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -13701.073% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -10731.924% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -41611.591% |
| OmniAb, Inc. | 25.56 Million USD | -1223.426% |
| Anew Medical, Inc. | 1.6 Million USD | -20976.698% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1043.503% |
| Lipocine Inc. | 17.16 Thousand USD | -1970545.462% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -2806.694% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -876.9% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5626.725% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -491.68% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -166540.887% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -6449.487% |
| Ocugen, Inc. | 6.94 Million USD | -4773.664% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2294.232% |
| Q32 Bio Inc. | 1.31 Million USD | -25566.237% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -50239.435% |
| Alumis Inc. Common Stock | 32.58 Million USD | -938.309% |
| Equillium, Inc. | 824 Thousand USD | -40953.519% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -3625.972% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -112358.196% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -122.116% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -561.506% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -43546.458% |
| Dominari Holdings Inc. | 3.02 Million USD | -11071.764% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -357918.563% |
| vTv Therapeutics Inc. | 529 Thousand USD | -63847.259% |
| Bio-Techne Corporation | 419.53 Million USD | 19.368% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -369.861% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -74.763% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1903.085% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1386.166% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -5484.038% |
| Nkarta, Inc. | 88.33 Million USD | -282.935% |
| BioCardia, Inc. | 1.31 Million USD | -25624.791% |
| Iterum Therapeutics plc | 19.5 Million USD | -1633.974% |